Cosmos Holdings (COSM) Company Long-Term Loans and Borrowings

Cosmos Health, Inc. - graphic logo of issuer COSM

The linear price action on the Cosmos Health Inc. (COSM) chart highlights the impact of private label expansion and the integration of AI into formula development, while long-term debt stands at 0.00. A steady cash flow is driven by regular supplies of vitamins and medications to pharmacies. Cosmos Health Inc. (COSM) is cultivating an image as an innovative health provider, strengthening its position within the European distribution market.

COSM Cosmos Health Inc.: Company Long-Term Debts in the range 04/28/2023 - 10/28/2026

Analytical breakdowns for Cosmos Health Inc.

- price and consensus price forecast:
Stock Price cosmosholdingsinc.com|COSM - Price Target Chart
- market capitalization data:
Market Value Cosmos Health|COSM - Total Company Value
- book capitalization data:
Accounting Value per Share Cosmos Health|COSM - Book Capitalization|Market Capitalization to Book Value Ratio cosmosholdingsinc.com|COSM - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Cosmos Health Inc.|COSM - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Cosmos Health Inc|COSM - Company Debts|Debts to Book Value Cosmos Health|COSM - Company Long-Term Debt|Company Short-Term Debt Cosmos Health
Fundamental valuation:cosmosholdingsinc.com (COSM)
Original product of Cosmos Health Inc

The defensive nature of pharmaceutical distribution provides Cosmos Health Inc. (COSM) with a stable cash flow, making the valuation of the business's long-term debt a key indicator of financial leverage. This metric aggregates all liabilities with maturities exceeding one year, allowing investors to compare the credit load against expansion rates and determine the company's resilience to long-term risks.

Competitors of Cosmos Health Inc. (COSM)

lilly.com - Company Long-Term Debts|Company Long-Term Debt AbbVie (ABBV)|AZN: Company Long-Term Loans and Borrowings|NVS (Novartis Inc.) - Company Long-Term Debt|MSD (MRK) - Company Long-Term Liabilities|NVO (Novo Nordisk A/S) - Company Long-Term Debts|Company Long-Term Debts amgen.com (AMGN)|Pfizer (PFE) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Sanofi SA (SNY)|Company Long-Term Debts BMS|GlaxoSmithKline plc - Company Long-Term Loans and Borrowings|TAK (Takeda Pharmaceutical) - Company Long-Term Debt|TEVA: Long-Term Debt|Dr. Reddy's (RDY) - Company Long-Term Debt|Viatris Inc (VTRS) - Company Long-Term Debt|Company Long-Term Debts Roivant Sciences Ltd (ROIV)|Company Long-Term Indebtedness Zai Lab Corp|BHC (Bausch Health Companies) - Company Long-Term Debts